-Responsible for the commercial segment performance management including identification of levers to optimize financial performance. -Provide strategic guidance and insights to inform key business decisions and analyze industry trends and the competitive landscape to identify opportunities and risks. -Partner with segment leadership and throughout the enterprise to develop and implement financial strategies to ensure the financial health and long-term growth of the commercial segments.

Strategic Leadership: Successfully lead and manage a team of ~10 professionals specializing in Competitive/Market Intelligence, Portfolio Insights, Brand & Therapeutic Area (TA) Insights, Performance Reporting, and Quantitative Insights/Data Science.Data-Driven Decision Making: Leveraging data analytics and insights, contributed to data-driven decision-making processes, resulting in optimized commercial strategies and market positioning.Market Insights: Developed a robust Competitive and Market Intelligence function, ensuring real-time updates on industry trends, competitor activities, and market dynamics,Brand & Therapeutic Area Insights: Led the Brand & Therapeutic Area Insights team to enhance brand performance globally, market dynamics, and partner to facilitate strategies related to the >10 Therapeutic Area by providing data-driven recommendations.Performance Reporting: Established an efficient Performance Reporting system, ensuring timely and accurate reports for global / regional stakeholders, enabling proactive adjustments to strategies and tactics, including focus areas requiring fire fighting and above-market intervention.Quantitative Insights & Data Science: Incubated and fostered a culture of data science and quantitative analysis, driving innovation and predictive modeling to guide business decisions.Stakeholder Engagement: Effectively communicated insights and recommendations to executive leaders / C-suite executives, fostering a deeper understanding

-Lead small agile team to partner with all 11 Global TA leads supporting all Global Key Brand leads across all facets of performance, from market performance deep dives to internal financial measurements- Owned segmentation of our brands into various clusters for analysis, tracking, and tactic implementation based on characteristics such as size, financial growth potential, and selling & marketing support required-Subject Matter expert and global point of contact on external market data (IQVIA) across multiple domains, such as national data, product projections, customer master data, and promotional data.

-Responsible for the development and management of data enablement for the entire Global Commercial Development organization, partnering with IT analytics and other Commercial Teams.

-Drive analytical insight and support for executives in multiple business areas, including commercial, market data, and financial key performance indicators and other areas of focus requiring executive attention-Analyze and monitor competitive intelligence landscape on both an enterprise and product level to generate strategic insights-Small Core team member responsible for the creation and deployment of the 5-year strategic planning process. Outputs & work streams included implementing a company first product level financial collection for 5-years of financials, business SWOT analysis, scenario planning, new business venture and business pruning analysis, and human capital needs over the near and mid-term-Sponsor development of visualization dashboards as well as analytical framework to succinctly present key business drivers for executive consumption-Key team member for developing external messaging for key company topics and events such as Investor Day as well as quarterly earnings calls and Q&A planned responses.

Served as subject matter expert for executive leadership team, (including Executive Chairman, CFO, and CEO,) on current sell side perceptions, competitor disclosures and messaging, and latest events and happenings in the pharmaceutical public realm.Prepared financial exhibits, information and analysis in preparation for quarterly and annual forecasts and earnings release as well as ad-hoc requests from senior management. Key member of team responsible for the creative content and messaging of Mylan's 2012 and 2013 Investor Day presentations. Post the 2013 Investor Day, Mylan's stock price increased more than 7% the next day, with multiple sell-side analysts writing that it was one of the most detailed analysts day presentations they had ever attended.Partnered with Corporate Finance to provide accurate, up to date senior level status reports on multiple subjects.

Part of two member team which was tasked with the the successful execution of the financial forecasting processes. The process consists of: a detailed Quarterly 18 month rolling forecast of Mylan's ~300 product families (which equated to more than 20B doses of volume and >$1B in revenue) , monthly Risk and Opportunity Reporting into the Regional CFO and Regional President, creation of three to five year strategic plans.Project Management experience as lead for North American initiative under the sponsorship of Canadian subsidiary President (details proprietary)Ad-hoc scenarios as requested from multiple internal customers ranging from supply chain, technical operations, selling & marketing, to North American Leadership Team.